Supernus Pharmaceuticals EBITDA 2011-2025 | SUPN

Supernus Pharmaceuticals ebitda from 2011 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Supernus Pharmaceuticals EBITDA 2011-2025 | SUPN

Supernus Pharmaceuticals ebitda from 2011 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M